» Articles » PMID: 10993110

Hydroxyurea Treatment for Chronic Myeloid Leukemia During Pregnancy

Overview
Publisher Wiley
Date 2000 Sep 19
PMID 10993110
Citations 16
Authors
Affiliations
Soon will be listed here.
Citing Articles

Chronic myeloid leukemia diagnosed in pregnancy: management and outcome of 87 patients reported to the European LeukemiaNet international registry.

Chelysheva E, Apperley J, Turkina A, Yassin M, Rea D, Nicolini F Leukemia. 2024; 38(4):788-795.

PMID: 38388649 PMC: 11408247. DOI: 10.1038/s41375-024-02183-0.


Management of Chronic Myeloid Leukemia and Pregnancy: A Bibliometric Analysis (2000-2020).

Wang Y, Jiang L, Li B, Zhao Y Front Oncol. 2022; 12:826703.

PMID: 35321439 PMC: 8934933. DOI: 10.3389/fonc.2022.826703.


Tyrosine kinase inhibitors and pregnancy in chronic myeloid leukemia: opinion, evidence, and recommendations.

Abruzzese E, Mauro M, Apperley J, Chelysheva E Ther Adv Hematol. 2020; 11:2040620720966120.

PMID: 33194164 PMC: 7607785. DOI: 10.1177/2040620720966120.


Hematological malignancies during pregnancy.

Barzilai M, Avivi I, Amit O Mol Clin Oncol. 2019; 10(1):3-9.

PMID: 30655971 PMC: 6313953. DOI: 10.3892/mco.2018.1759.


The teratogenic effects of imatinib mesylate on rat fetuses.

El Gendy M, Kandil A, Helal M, Zahou F Toxicol Rep. 2017; 2:654-663.

PMID: 28962401 PMC: 5598385. DOI: 10.1016/j.toxrep.2015.05.001.